title: [The level of 8-iso-prostaglandin F2 alpha, 4-hydroxynonenal and malondialdehyde in alcohol dependent men during combined therapy].
abstract: The aim of the study was the estimation of intensity of lipid peroxidation in alcohol dependent male patients after three months of therapy with naltrexone or tianeptine and the next three months follow-up. 61 males with clinical diagnosis of alcohol dependence (ICD-10) have been examined. The investigated parameters have been determined in blood serum, the 8-iso-prostaglandin F2 alpha by means of immunoenzymatic assay (ELISA) and malondialdehyde with 4-hydroxynonenal by means of colorimetric method. In alcohol dependent men before pharmacotherapy the mean concentration of 8-iso-PGF2 alpha and [MDA + 4-HNE] was higher than the reference interval. Both, after three months of applied drugs and the next three months follow-up, the concentration of studied parameters decreased considerably. The above results show intensification of lipid peroxidation in alcohol abusers and advantageous influence of abstinence from alcohol and treatment of naltrexone or tianeptine on free-radical changes of lipids as well.
authors.affiliation: Katedry i Zakładu Patobiochemii i Chemii Klinicznej AM w Bydgoszczy.
authors.forename: Ewa
authors.initials: E
authors.lastname: Kopczyńska
authors.forename: Magdalena
authors.initials: M
authors.lastname: Lampka
authors.forename: Lech
authors.initials: L
authors.lastname: Torliński
authors.forename: Marcin
authors.initials: M
authors.lastname: Ziółkowski
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D000447:Aldehydes / Q000097:blood*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D015237:Dinoprost / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D028441:F2-Isoprostanes / Q000097:blood*; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008315:Malondialdehyde / Q000097:blood*; D008875:Middle Aged; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000447:Aldehydes; D000929:Antidepressive Agents, Tricyclic; D028441:F2-Isoprostanes; D009292:Narcotic Antagonists; D013841:Thiazepines; C050504:tianeptine; C075750:8-epi-prostaglandin F2alpha; D008315:Malondialdehyde; D009271:Naltrexone; D015237:Dinoprost; C027576:4-hydroxy-2-nonenal